W L Fodor

Author PubWeight™ 17.94‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord. Nat Biotechnol 2000 1.76
2 Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med 1995 1.70
3 Dissection of the interferon gamma-MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s). EMBO J 1992 1.32
4 A novel mechanism of retrovirus inactivation in human serum mediated by anti-alpha-galactosyl natural antibody. J Exp Med 1995 1.28
5 Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 1994 1.13
6 The activation of major histocompatibility complex class I genes by interferon regulatory factor-1 (IRF-1). Immunogenetics 1992 0.95
7 Down-regulation of Gal alpha(1,3)Gal expression by alpha1,2-fucosyltransferase: further characterization of alpha1,2-fucosyltransferase transgenic mice. Transplantation 1997 0.91
8 Reactivation of a major histocompatibility complex class II gene in mouse plasmacytoma cells and mouse T cells. J Exp Med 1992 0.85
9 Human embryonic/atrial myosin alkali light chain gene: characterization, sequence, and chromosomal location. Genomics 1990 0.85
10 Expression of the human alpha1,2-fucosyltransferase in transgenic pigs modifies the cell surface carbohydrate phenotype and confers resistance to human serum-mediated cytolysis. FASEB J 1999 0.84
11 Comparative analysis of three genetic modifications designed to inhibit human serum-mediated cytolysis. Xenotransplantation 1999 0.83
12 Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation. J Thorac Cardiovasc Surg 2000 0.83
13 Primary structure and functional characterization of a soluble, alternatively spliced form of B7-1. J Immunol 2000 0.80
14 Strategies to overcome the anti-Gal alpha (1-3)Gal reaction in xenotransplantation. Transplant Proc 1996 0.78
15 Use of porcine tumor necrosis factor receptor 1-Ig fusion protein to prolong xenograft survival. Xenotransplantation 2004 0.77
16 Characterization of cartilage from H-transferase transgenic pigs. Transplant Proc 2008 0.77
17 Expression of human CD59 in transgenic pig organs enhances organ survival in an ex vivo xenogeneic perfusion model. Transplantation 1996 0.77
18 Laboratory studies in cross-species lung transplantation. World J Surg 1997 0.75
19 Enhanced survival of porcine endothelial cells and lung xenografts expressing human CD59. Transplant Proc 1996 0.75
20 Characterization of porcine tumor necrosis factor receptor 2: implications for xenotransplantation. Transplant Proc 2007 0.75